Kabuki syndrome and rare tumors in a young girl carrying a frameshift KMT2D mutation

Abstract

Kabuki syndrome (KS) is a genetic disorder characterized by typical facial dimorphisms, various degrees of cognitive disability, and congenital anomalies involving the heart, kidneys, gastrointestinal system, and bones. It is accompanied by hypotonia, failure to thrive, obesity, and immunodeficiency. Association with neoplastic lesions has been recently described. We report a 13-year-old girl with KS, an insulinoma, and a benign phyllodes breast tumor with two hepatic lesions: a neuroendocrine tumor metastasis and a ciliated foregut cyst associated with hepatic fibrosis. She had a pilomatrixoma and a junctional melanocytic nevus with cytological atypia. Genetic analysis revealed a heterozygous frameshift variant in the KMT2D gene. Somatic KMT2D variants are in various types of tumors. The role of KMT2D variants in malignancies in KS appears to be related to defective transcription regulation and altered gene expression; however, the mechanism remains unclear. This aims to clarify the relationship between KMT2D gene variants, KS, and susceptibility to neoplastic lesions. For this purpose, a more extensive case series will be needed to accurately describe the patients' neoplastic phenotypes and precise genetic characterization.

Keywords

Kabuki syndrome / KMT2D gene / neoplastic lesions

References

[1] AdamMP,HannibalM.Kabuki syndrome. GeneReviews®. Seattle: University of Washington; 2011.

[2] AdamMP,BjornssonHT.Kabuki Syndrome Medical Advisory BoardKabuki syndrome: international consensus diagnostic criteria.J Med Genet2019;56:89-95

[3] BarryKK,HoffmanD.From genotype to Phenotype-A review of kabuki syndrome.Genes2022;13:1761 PMCID:PMC9601850

[4] AristizábalE,CandeloE.A novel intronic KMT2D variant as a cause of kabuki syndrome: a case report.Appl Clin Genet2021;14:409-16 PMCID:PMC8502069

[5] CocciadiferroD,DeNittis P.Dissecting KMT2D missense mutations in Kabuki syndrome patients.Hum Mol Genet2018;27:3651-68 PMCID:PMC6488975

[6] WangYR,WangJ.Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms.World J Pediatr2019;15:528-35.

[7] FroimchukE,GeK.Histone H3 lysine 4 methyltransferase KMT2D.Gene2017;627:337-42 PMCID:PMC5546304

[8] TeranishiH,NakashimaK.Cancer management in kabuki syndrome: the first case of wilms tumor and a literature review.J Pediatr Hematol Oncol2018;40:391-4

[9] BernierFE,CoulombeJ,MarcouxD.Pilomatricoma associated with kabuki syndrome.Pediatr Dermatol2017;34:e26-7

[10] RomaD,CapolinoR.Spinal ependymoma in a patient with Kabuki syndrome: a case report.BMC Med Genet2015;16:80 PMCID:PMC4560867

[11] BonielS,ŚmigielR.Kabuki syndrome-clinical review with molecular aspects.Genes2021;12:468 PMCID:PMC8064399

[12] deBilly E,CacchioneA.Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation.Am J Med Genet A2019;179:113-7

[13] AukemaSM,vanden Hout MFCM.Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes.Fam Cancer2023;22:103-18 PMCID:PMC9829644

[14] Herodež ŠŠ,KrgovićD.De novo KMT2D heterozygous frameshift deletion in a newborn with a congenital heart anomaly.Balkan J Med Genet2020;23:83-90 PMCID:PMC7474217

[15] WangH,WangCF.Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.Asian Pac J Cancer Prev2014;15:10791-5

[16] StrodeM,MangieriC.Update on the diagnosis and management of malignant phyllodes tumors of the breast.Breast2017;33:91-6.

[17] BögershausenN,BeleggiaF.An unusual presentation of Kabuki syndrome with orbital cysts, microphthalmia, and cholestasis with bile duct paucity.Am J Med Genet A2016;170:3282-8

[18] BishopKC,RuzinovaMB.Ciliated hepatic foregut cyst: a report of 6 cases and a review of the English literature.Diagn Pathol2015;10:81. PMCID:PMC4486693